1. Home
  2. FUSE vs RNXT Comparison

FUSE vs RNXT Comparison

Compare FUSE & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FUSE

Fusemachines Inc.

N/A

Current Price

$1.23

Market Cap

40.8M

Sector

Technology

ML Signal

N/A

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.85

Market Cap

37.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUSE
RNXT
Founded
2013
2012
Country
United States
United States
Employees
270
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.8M
37.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FUSE
RNXT
Price
$1.23
$0.85
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.25
AVG Volume (30 Days)
86.1K
323.5K
Earning Date
06-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.00
EPS
N/A
N/A
Revenue
N/A
$1,123,000.00
Revenue This Year
N/A
$194.66
Revenue Next Year
N/A
$279.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2511.63
52 Week Low
$0.80
$0.70
52 Week High
$3.67
$1.45

Technical Indicators

Market Signals
Indicator
FUSE
RNXT
Relative Strength Index (RSI) 39.56 44.34
Support Level $0.80 $0.78
Resistance Level $1.44 $1.07
Average True Range (ATR) 0.09 0.07
MACD -0.02 -0.01
Stochastic Oscillator 22.66 4.29

Price Performance

Historical Comparison
FUSE
RNXT

About FUSE Fusemachines Inc.

Fusemachines Inc is a provider of enterprise AI solutions, offering products such as AI Studio, AI Engines, and AI Agents, along with supporting services across various industries. Its solutions are supported by a talent pool from underserved communities, enabling scalable and high-quality AI delivery while promoting access to AI. The Company serves clients across industries, including healthcare, media, technology, and government, helping address challenges such as improving forecasting accuracy, reducing data entry errors, automating recruitment, and detecting fraud. Its product suite includes AI Studio, AI Engines, and AI Agents, designed to build, deploy, and scale AI solutions, and it operates in Nepal and the United States.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: